Superparamagnetic particles as an oral contrast agent in abdominal magnetic resonance imaging.
Oksendal
A N
AN
Nycomed AS, Oslo, Norway.
Jacobsen
T F
TF
Gundersen
H G
HG
Rinck
P A
PA
Rummeny
E
E
D000005:Abdomen / Q000473:pathology*; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects; D003911:Dextrans; D004341:Drug Evaluation; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage / Q000009:adverse effects; D052203:Ferrosoferric Oxide; D006801:Humans; D007501:Iron / Q000008:administration & dosage / Q000009:adverse effects; D008279:Magnetic Resonance Imaging / Q000379:methods*; D058185:Magnetite Nanoparticles; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage / Q000009:adverse effects
D003287:Contrast Media; D003911:Dextrans; D005290:Ferric Compounds; D058185:Magnetite Nanoparticles; D010087:Oxides; C001215:ferrite; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide